Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the feasibility of adding induction and maintenance Avelumab to the standard
combination of R-CHOP in patients with stage II, III and IV diffuse large B cell lymphoma
(DLBCL)